Medical device manufacturers have long been seeking an end to a 2.3 percent tax levied on their products that is included in the Patient Protection and Affordable Care Act.

And now the multi-billion dollar industry is hoping it can get that repeal, which has garnered support from both sides of the aisle, through Congress before the end of the year.

Recently, most of the debate over PPACA taxes has focused on the "Cadillac Tax," a provision of the law that levies a 40-percent excise tax on health plans that cost more than $10,200 for individuals or $27,500 for families.

Recommended For You

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.